rab3b-protein

RAB3B Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">rab3b-protein</th>
</tr>
<tr>
<td class="label">Effector Protein</td>
<td>Interaction Domain</td>
</tr>
<tr>
<td class="label">RIM1α/2α</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Rabphilin-3A</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Munc13-1/2</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Synaptotagmin-1</td>
<td>Via RIM</td>
</tr>
<tr>
<td class="label">Munc18-1</td>
<td>Via syntaxin</td>
</tr>
<tr>
<td class="label">Granuphilin</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Exophilin-8</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">32 edges</a></td>
</tr>
</table>

Introduction

RAB3B Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">rab3b-protein</th>
</tr>
<tr>
<td class="label">Effector Protein</td>
<td>Interaction Domain</td>
</tr>
<tr>
<td class="label">RIM1α/2α</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Rabphilin-3A</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Munc13-1/2</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Synaptotagmin-1</td>
<td>Via RIM</td>
</tr>
<tr>
<td class="label">Munc18-1</td>
<td>Via syntaxin</td>
</tr>
<tr>
<td class="label">Granuphilin</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Exophilin-8</td>
<td>RAB3-binding domain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/depression" style="color:#ef9a9a">Depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">32 edges</a></td>
</tr>
</table>

Introduction

RAB3B (Ras-Related Protein Rab-3B) is a neuronal small GTPase that plays a critical role in regulating synaptic vesicle trafficking and neurotransmitter release. As a member of the RAB3 family (RAB3A, RAB3B, RAB3C, RAB3D), RAB3B is specifically expressed in neurons and neuroendocrine cells, where it functions as a molecular switch controlling vesicle dynamics essential for synaptic communication.[@h2025] The RAB3B protein is encoded by the RAB3B gene located on chromosome 1p31.1 and belongs to the larger RAB GTPase family, which are key regulators of intracellular membrane trafficking in eukaryotic cells.

Unlike RAB3A, which is the most abundant RAB protein in synaptic vesicles and broadly expressed throughout the brain, RAB3B shows a more restricted expression pattern with particularly high levels in specific neuronal populations including hippocampal CA3 pyramidal neurons, cortical layer 5 pyramidal neurons, cerebellar granule cells, and spinal cord motor neurons [1].[@t2011] This selective expression suggests specialized functions for RAB3B in particular neural circuits and synaptic populations.

The RAB3B protein undergoes a characteristic GTP/GDP cycling that regulates its association with synaptic vesicles and interactions with downstream effector proteins. In the active GTP-bound state, RAB3B is associated with synaptic vesicle membranes and can interact with various effector proteins that regulate vesicle docking, priming, fusion, and recycling.[@n2008] Upon GTP hydrolysis to the GDP-bound state, RAB3B dissociates from the vesicle membrane and becomes cytosolic, ready for another cycle of vesicle trafficking regulation [2].

Protein Structure and Domains

GTPase Domain Architecture

RAB3B contains the characteristic structural features of Rab GTPases:

G-domain (residues 1-180): The core GTPase domain adopts a conserved fold consisting of six β-strands surrounded by five α-helices. This domain contains the critical structural elements required for nucleotide binding and hydrolysis:

• P-loop (phosphate-binding loop, residues 15-22): The sequence GxxxxGKST forms the phosphate-binding loop that coordinates the phosphate groups of GTP/GDP. This motif is essential for nucleotide binding and is conserved across all GTP-binding proteins.
• Switch I region (residues 32-45): This flexible loop undergoes dramatic conformational changes between the GTP-bound (active) and GDP-bound (inactive) states. The Switch I region interacts with regulatory proteins including GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs).
• Switch II region (residues 57-70): Similar to Switch I, this region undergoes nucleotide-dependent conformational changes and is critical for GTP hydrolysis. The DxxG motif within Switch II coordinates magnesium ion, which is essential for catalytic activity.
• Effector region (residues 75-95): A variable region that mediates interactions with downstream effector proteins. The sequence and structure of this region determine effector specificity among different Rab proteins.

Hypervariable C-terminal Region

Residues 181-205: The C-terminal region of RAB3B contains a hypervariable domain that determines subcellular localization and membrane association specificity. This region shows greater sequence variation between Rab family members compared to the conserved GTPase domain.

C-terminal cysteine motif (residues 206-219): RAB3B terminates with the sequence CaaX (Cysteine-aliphatic-aliphatic-any), where C is cysteine, a represents aliphatic amino acids, and X is any residue. This motif undergoes post-translational prenylation (geranylgeranylation) at the cysteine residue, followed by proteolytic cleavage of the aaX portion and carboxymethylation of the resulting C-terminal cysteine. These lipid modifications anchor RAB3B to synaptic vesicle membranes and are essential for its biological function [3].

Post-Translational Modifications

RAB3B undergoes several post-translational modifications that regulate its function:

• Prenylation: Geranylgeranylation at the C-terminal cysteine is required for membrane association and proper function.
• Phosphorylation: Multiple serine and threonine residues can be phosphorylated, potentially regulating effector interactions.
• Palmitoylation: Additional lipid modifications may occur on cysteine residues near the C-terminus.
• Ubiquitination: Can target RAB3B for degradation and regulate its turnover.

Molecular Function

Synaptic Vesicle Trafficking Regulation

RAB3B regulates multiple stages of the synaptic vesicle cycle [4]:

1. Vesicle Recruitment and Docking:
RAB3B-GTP associates with synaptic vesicles as they approach the presynaptic active zone. The active RAB3B interacts with active zone scaffold proteins including RIM (Rab3-Interacting Molecule) proteins, which help position vesicles near release sites. RAB3B-mediated recruitment ensures that vesicles are properly positioned for release.

2. Vesicle Priming:
RAB3B participates in the priming step that prepares synaptic vesicles for fusion-competent states. Through interactions with Munc13 and other priming factors, RAB3B helps regulate the transition of vesicles from the docked state to the readily releasable pool (RRP). This priming function is critical for determining the size of the RRP and the capacity for sustained neurotransmission.

3. Fusion Regulation:
RAB3B modulates SNARE complex formation and the final fusion step. While RAB3A is more directly involved in triggering fusion, RAB3B contributes to the regulation of fusion kinetics and the coordination between Ca²⁺ influx and vesicle release. The RAB3B effector rabphilin can interact with SNARE proteins, linking RAB3B function to the fusion machinery.

4. Vesicle Recycling:
Following fusion, RAB3B participates in synaptic vesicle recycling by regulating the retrieval of vesicle components and the reformation of synaptic vesicles. The GTP/GDP cycle of RAB3B coordinates with endocytosis and vesicle reloading processes.

Neurotransmitter Release Modulation

RAB3B influences several parameters of synaptic transmission:

Release Probability:
RAB3B modulates the probability that a synaptic vesicle will release neurotransmitters upon arrival of an action potential. Through its effects on vesicle priming and the coupling between Ca²⁺ influx and fusion, RAB3B helps determine baseline release probability.

Quantal Size:
The amount of neurotransmitter released per vesicle (quantal size) can be influenced by RAB3B function through effects on vesicle filling and the number of neurotransmitter molecules per vesicle.

Short-Term Plasticity:
RAB3B contributes to short-term plasticity mechanisms including facilitation and depression. The kinetics of RAB3B GTP/GDP cycling may influence how synapses adapt to trains of action potentials.

Synaptic Homeostasis:
RAB3B participates in homeostatic scaling and compensatory mechanisms that maintain stable synaptic output despite changes in activity.

Effector Protein Interactions

RAB3B interacts with multiple effector proteins that mediate its downstream functions [5]:

Expression Pattern

Tissue-Specific Distribution

RAB3B exhibits a characteristic expression pattern with highest levels in neuronal and neuroendocrine tissues:

High Expression:

• Brain (specific neuronal populations)
• Adrenal medulla
• Pituitary gland
• Neuroendocrine cells

• Spinal cord
• Peripheral nervous system
• Some endocrine tissues

Brain Region Distribution

RAB3B shows region-specific expression within the brain:

High Expression Regions:

• Hippocampus: Particularly in CA3 pyramidal neurons and mossy fiber terminals
• Cerebral Cortex: Layer 5 pyramidal neurons show high RAB3B expression
• Cerebellum: Granule cell layer and deep cerebellar nuclei
• Basal Ganglia: Substantia nigra pars compacta (dopaminergic neurons)
• Spinal Cord: Motor neurons in anterior horns

• Synaptic vesicles in presynaptic terminals
• Cytoplasmic pools in axon terminals
• Association with secretory granules in neuroendocrine cells

Developmental Regulation

RAB3B expression changes during development:

• Low expression in embryonic brain
• Gradual increase during postnatal development
• Peak expression in mature neurons
• Sustained expression in adulthood with potential age-related changes

Regulation of RAB3B Function

Guanine Nucleotide Exchange Factors (GEFs)

RAB3B GEFs catalyze the exchange of GDP for GTP, activating RAB3B:

• RAB3GEF (RAB3GEP): The major RAB3B GEF that promotes GTP loading
• Dendrin: Neuron-specific GEF involved in RAB3B regulation
• Rabin8: RAB3B GEF with roles in vesicle trafficking

GTPase-Activating Proteins (GAPs)

RAB3B GAPs accelerate GTP hydrolysis, promoting the inactive state:

• RAB3GAP1: Catalytic subunit of RAB3GAP complex
• RAB3GAP2: Non-catalytic subunit
• EVI5-like proteins: Brain-expressed GAPs for RAB3B

Guanine Nucleotide Dissociation Inhibitors (GDIs)

RAB3B GDIs extract GDP-bound RAB3B from membranes:

• RAB3DIs: Regulate RAB3B availability and recycling
• RAB3DIs: Control RAB3B membrane cycling

Disease Associations

Alzheimer's Disease

RAB3B is strongly implicated in Alzheimer's disease pathophysiology [6]:

Synaptic Vesicle Dysfunction:

• Altered RAB3B expression in AD brain regions (hippocampus, cortex)
• Impaired RAB3B-mediated vesicle trafficking contributes to synaptic failure
• Changes in RAB3B-GTP/GDP cycling affect vesicle pool dynamics

• Amyloid-β (Aβ) oligomers can disrupt RAB3B effector interactions
• Tau pathology affects RAB3B distribution and function in neurons
• RAB3B dysfunction contributes to neurotransmitter release deficits

• RAB3B modulators could potentially restore synaptic function
• RAB3B as biomarker for synaptic integrity in AD
• Gene therapy approaches to enhance RAB3B function

Parkinson's Disease

RAB3B plays important roles in dopaminergic neuron function relevant to PD [7]:

Dopaminergic Synapse Function:

• High RAB3B expression in substantia nigra dopaminergic neurons
• Regulates dopamine release from synaptic vesicles
• Controls vesicle pool size in dopaminergic terminals

• α-Synuclein can interact with RAB3B and affect its function
• RAB3B-mediated vesicle trafficking disrupted in α-synucleinopathy
• Potential for RAB3B-targeted interventions

• RAB3B modulators could enhance dopaminergic neurotransmission
• RAB3B in disease models shows promise for intervention
• Biomarker potential for disease progression

Amyotrophic Lateral Sclerosis (ALS)

RAB3B dysfunction contributes to ALS pathophysiology [8]:

Motor Neuron Dysfunction:

• Altered RAB3B expression in ALS motor neurons
• Impaired synaptic vesicle recycling at neuromuscular junctions
• RAB3B in vulnerable motor neuron populations

• TDP-43 pathology affects RAB3B mRNA processing
• RAB3B in sporadic and familial ALS
• Synaptic dysfunction as early event in ALS

• RAB3B-targeted approaches for motor neuron protection
• Enhancing synaptic function at neuromuscular junctions

Schizophrenia

RAB3B is implicated in schizophrenia through synaptic dysfunction [9]:

Expression Changes:

• Altered RAB3B expression in prefrontal cortex
• RAB3B in glutamatergic and GABAergic dysfunction
• Implications for working memory and executive function

• RAB3B polymorphisms associated with schizophrenia risk
• RAB3B in schizophrenia GWAS signals
• Potential for RAB3B as therapeutic target

Epilepsy

RAB3B contributes to epileptogenesis:

Altered Function:

• RAB3B dysregulation in seizure-prone brain regions
• Contribution to excessive neurotransmission
• RAB3B in temporal lobe epilepsy

Biomarker Applications

RAB3B as Diagnostic Marker

Cerebrospinal Fluid (CSF):

• RAB3B levels in CSF reflect synaptic integrity
• Potential for differentiating neurodegenerative conditions
• Correlates with disease severity

• Peripheral RAB3B measurement as indirect marker
• RAB3B in extracellular vesicles
• Potential for disease monitoring

Therapeutic Monitoring

RAB3B as biomarker for treatment response:

• Changes in RAB3B with disease-modifying therapies
• RAB3B as pharmacodynamic marker
• Monitoring synaptic function recovery

Therapeutic Implications

Small Molecule Modulators

GTPase Activity Modulators:

• Compounds targeting RAB3B GTP/GDP cycle
• Allosteric modulators of RAB3B function

• Peptide inhibitors of RAB3B-effector interactions
• Small molecules targeting specific interactions

• Compounds enhancing vesicle cycling
• Modulators of release probability

Gene Therapy Approaches

Viral Vector Delivery:

• AAV-mediated RAB3B overexpression
• Neuron-specific promoters for targeted expression
• Conditional expression systems

• siRNA approaches for RAB3B knockdown
• CRISPR-based editing for precise modulation
• Allele-specific approaches

Combination Strategies

RAB3B-targeted therapies in combination:

• RAB3B modulation with other synaptic targets
• RAB3B with disease-modifying approaches
• Synaptic protection plus functional enhancement

Animal Models

Knockout and Transgenic Models

RAB3B Knockout Mice:

• Viable and fertile with subtle phenotypes
• Compensatory upregulation of other RAB3 isoforms
• Mild synaptic transmission deficits

• More severe synaptic phenotypes
• Enhanced deficits compared to single knockouts
• Reveals functional redundancy

• Neuron-specific deletion
• Developmental stage-specific ablation
• Region-specific knockouts

• Wild-type RAB3B overexpression
• Dominant-negative constructs
• Disease-associated mutants

Disease Models

• AD models: RAB3B in APP/PS1 and Tau models
• PD models: RAB3B in alpha-synuclein models
• ALS models: RAB3B in SOD1 and TDP-43 models

Interaction Network

Protein-Protein Interactions

Core Network:

• RAB3B → RIM1α → Munc13 → Synaptotagmin
• RAB3B → Rabphilin → Synapsin
• RAB3B → Munc18 → Syntaxin

• Ca²⁺/Calmodulin-dependent pathways
• PKA-mediated phosphorylation
• PI3K/Akt signaling

Genetic Interactions

RAB3B interacts genetically with:

• Other RAB3 isoforms
• SNARE complex components
• Active zone proteins
• Cytoskeletal regulators

Research Methods

Experimental Approaches

Biochemistry:

• Co-immunoprecipitation studies
• GTPase activity assays
• Pull-down assays with effector domains

• Live-cell imaging of RAB3B dynamics
• FRAP (Fluorescence Recovery After Photobleaching)
• Total internal reflection fluorescence (TIRF) microscopy

• Patch-clamp recordings
• Capacitance measurements
• Paired recordings

• Knockout and transgenic mice
• iPSC-derived neurons
• CRISPR editing

Pathway Diagram

Future Directions

Unresolved Questions

• What is the precise molecular mechanism of RAB3B in different vesicle pool regulations?
• How does RAB3B coordinate with other RAB3 isoforms?
• What determines cell-type-specific functions of RAB3B?
• Can RAB3B modulation provide therapeutic benefit in human disease?

Emerging Research Areas

• Single-cell sequencing to define RAB3B-expressing neuron populations
• Cryo-EM structures of RAB3B-effector complexes
• RAB3B in extracellular vesicle biology
• RAB3B-based biomarkers for clinical trials

See Also

• [RAB3B Gene](/genes/rab3b)
• [RAB3A Protein](/proteins/rab3a-protein)
• [RAB3C Protein](/proteins/rab3c-protein)
• [Synaptotagmin-1 Protein](/proteins/synaptotagmin-1-protein)
• [Synapsin-1 Protein](/proteins/synapsin-1-protein)
• [SNARE Complex](/proteins/snare-complex)
• [Synaptic Vesicle Trafficking](/mechanisms/synaptic-vesicle-trafficking)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Schizophrenia](/diseases/schizophrenia)

External Links

• [UniProt: Q8WVN8](https://www.uniprot.org/uniprot/Q8WVN8)
• [NCBI Gene: RAB3B](https://www.ncbi.nlm.nih.gov/gene/10537)
• [Ensembl: RAB3B](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000169258)

References